About Us

Oculus Research is a patient focused clinical research company. We were founded in 2012 and are based in Raleigh, North Carolina. Our research studies encompass all ages from young children to geriatric patients. We specialize in ophthalmic research studies, including glaucoma/ocular hypertension, adenoviral and bacterial conjunctivitis, blepharitis, keratoconjunctivitis sicca (dry eye), myopia control, presbyopia, and devices such as contact lenses.

what we do?

All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. search for ‘lorem ipsum’ will uncover many web sites.

Lorem Ipsum which looks reasonable randomised words which don’t look even slightly believable The generated Lorem Ipsum is therefore always free from repetition, injected humour, or charac words.

winning awards

  • Lorem ipsum dolor consec tetuerdolor adipis
  • Suspendisse imperdiet cursusdolor aecenas
  • Fermentum sit amet vestibulum dolor pretium
  • Magna sem iaculis risus quis dolor consec volutpats
  • Vivamus risus Aliquam lacinia dolor consec nibh
  • Suspendisse imperdiet cursus dolor maecenas

Meet Oculus Research

Hoda Gabriel – President

Hoda Gabriel is a clinical research and development professional with 28 years of experience directing, designing, planning, and successfully executing early and late phase clinical drug programs within the pharmaceutical industry. As well as being the President of Oculus Research, Ms. Gabriel is currently the Sr. Director of Clinical Development at T3D Therapeutics. Prior to her current positions, she held director‐level positions with GlaxoSmithKline and Talecris (now Grifols), where she led several international programs and teams to successful NDA/MAA submissions. Additionally, she founded two independent clinical research companies. Ms. Gabriel has experience in the development of multiple therapeutic areas including CNS, Urology, Metabolic, Cardiovascular, Pain, Dermatology and Peripheral Arterial Disease.

Rosemarie Pladna – Clinical Operations Director

Rosemarie Pladna is a Clinical Operations Director for Oculus Research (OR). She received her BA in Biology and Associate Degree in Nursing at Youngstown State University. Prior to joining OR, she worked  in the Pharmaceutical Industry for over 21 years. Rosemarie’s career at GlaxoSmithKline included experience as a Senior Clinical Research Scientist, Clinical Compliance Manager and ultimately an Account Director for R&D Internal Audit. She was the recipient of a Platinum Award for her successful work in hosting FDA inspections in France, Germany and the USA, keeping the company in good standing. She provides guidance to the OR staff with regard to Good Clinical Practice in the conduct of human subject research.

Carol Aune, OD – Investigator and Director of Research

Carol Aune, OD is a graduate of the University of North Carolina at Chapel Hill and University of Houston College of Optometry. She is a practicing optometrist as well as a principal investigator for Oculus Research. She has years of experience diagnosing and treating a wide variety of eye disease as well fitting specialty contact lenses. She has been fully trained in clinical research including current GCP training.  As the Principal Investigator and Research Director for Oculus Research she implements clinical trial protocols, clinical diagnoses and supervises patient care. She performs all clinical investigator responsibilities and supervision of study staff and site personnel.